It was not until a genomic study was performed that the patient was found to harbor concurrent ASXL1, SETBP1, and NRAS mutations, which, combined with other morphological and laboratory features, supported a definitive diagnosis of aCML. This evidence concerns the gene NRAS and atypical chronic myeloid leukemia, BCR-ABL1 negative.